China Peanut Allergy Treatment Market Size & Outlook

The peanut allergy treatment market in China is expected to reach a projected revenue of US$ 64.9 million by 2030. A compound annual growth rate of 14.3% is expected of China peanut allergy treatment market from 2024 to 2030.
Revenue, 2023 (US$M)
$25.5
Forecast, 2030 (US$M)
$64.9
CAGR, 2024 - 2030
14.3%
Report Coverage
China

China peanut allergy treatment market, 2018-2030 (US$M)

China

China peanut allergy treatment market highlights

  • The China peanut allergy treatment market generated a revenue of USD 25.5 million in 2023 and is expected to reach USD 64.9 million by 2030.
  • The China market is expected to grow at a CAGR of 14.3% from 2024 to 2030.
  • In terms of segment, epinephrine was the largest revenue generating drug class in 2023.
  • Immunotherapies is the most lucrative drug class segment registering the fastest growth during the forecast period.


Peanut allergy treatment market data book summary

Market revenue in 2023USD 25.5 million
Market revenue in 2030USD 64.9 million
Growth rate14.3% (CAGR from 2023 to 2030)
Largest segmentEpinephrine
Fastest growing segmentImmunotherapies
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAntihistamines, Epinephrine, Immunotherapies, Other Drug Class
Key market players worldwideNestle SA, Sanofi SA, DBV Technologies SA ADR, PureTech Health PLC, Regeneron Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd ADR, Protagonist Therapeutics Inc, Aravax, Alladapt Immunotherapeutics


Other key industry trends

  • In terms of revenue, China accounted for 5.3% of the global peanut allergy treatment market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China peanut allergy treatment market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 56.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Peanut Allergy Treatment Market Companies

Name Profile # Employees HQ Website

China peanut allergy treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peanut allergy treatment market will help companies and investors design strategic landscapes.


Epinephrine was the largest segment with a revenue share of 48.63% in 2023. Horizon Databook has segmented the China peanut allergy treatment market based on antihistamines, epinephrine, immunotherapies, other drug class covering the revenue growth of each sub-segment from 2018 to 2030.


Peanut allergies appear to be a significant concern in Western countries but are notably less prevalent in other parts of the world, particularly in China. For instance, in Beijing, food allergies represent only a small percentage, ranging from 3.4% to 5.0% of all allergies, and these allergies are primarily associated with foods such as fish, shrimp, seaweed, and crab, rather than peanuts.

Interestingly, the Chinese-American community residing in the U.S. experiences a similar prevalence of peanut allergy as other American populations, highlighting potential environmental or lifestyle factors contributing to this difference.

Reasons to subscribe to China peanut allergy treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of China peanut allergy treatment market databook

  • Our clientele includes a mix of peanut allergy treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the China peanut allergy treatment market , including forecasts for subscribers. This country databook contains high-level insights into China peanut allergy treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

China peanut allergy treatment market size, by drug class, 2018-2030 (US$M)

China Peanut Allergy Treatment Market Outlook Share, 2023 & 2030 (US$M)

China peanut allergy treatment market size, by drug class, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more